![De Gui Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 19 M $ in data 30/06/2026
De Gui Lai occupa la posizione di Chief Financial & Accounting Officer, Deputy GM presso Sichuan Kelun Pharmaceutical Co., Ltd. e Manager-Finance & Accounting presso Chengdu Nymph Group Co.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/06/2026 | 349.000 ( 0,2% ) | 19 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Direttore Finanziario/CFO | 23/10/2014 |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 20/06/2024 |
Chengdu Nymph Group Co., Ltd.
 Chengdu Nymph Group Co., Ltd. Chengdu Nymph Group Co., Ltd. is a large integrated joint-stock enterprise specializing in the research, development, production, and sales of daily chemical products, focusing primarily on detergents and personal care products. The company integrates advanced production technology with traditional herbal knowledge and collaborates with institutions like Chengdu University of Traditional Chinese Medicine. The company is based in Chengdu, China. The Chinese company operates two major production bases, employs over 580 people including more than 220 technical professionals, and holds multiple production licenses and certifications such as ISO9001, ISO14001, and ISO45001. Its brands include detergent lines like "Red Rose," "Red Hibiscus," and "Double Cat," as well as cosmetic and personal care brands such as "Chunjuan," "Chunjuan Huangqi," "Chunjuan Baby," "Forest Morning," "Urban Baby," and "Dushi Beibei." Its marketing network covers over 235,000 sales outlets nationwide, with detergents mainly distributed in the southwest and cosmetics reaching all provinces. | Direttore Finanziario/CFO | - |
Sichuan Kelun Pharmacy Institute Co., Ltd.
 Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Direttore/Membro del Consiglio | 05/11/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Sichuan Kelun Pharmaceutical Co., Ltd.
 Sichuan Kelun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes intravenous solution products | Health Technology |
Chengdu Nymph Group Co., Ltd.
Chengdu Nymph Group Co., Ltd. Chengdu Nymph Group Co., Ltd. is a large integrated joint-stock enterprise specializing in the research, development, production, and sales of daily chemical products, focusing primarily on detergents and personal care products. The company integrates advanced production technology with traditional herbal knowledge and collaborates with institutions like Chengdu University of Traditional Chinese Medicine. The company is based in Chengdu, China. The Chinese company operates two major production bases, employs over 580 people including more than 220 technical professionals, and holds multiple production licenses and certifications such as ISO9001, ISO14001, and ISO45001. Its brands include detergent lines like "Red Rose," "Red Hibiscus," and "Double Cat," as well as cosmetic and personal care brands such as "Chunjuan," "Chunjuan Huangqi," "Chunjuan Baby," "Forest Morning," "Urban Baby," and "Dushi Beibei." Its marketing network covers over 235,000 sales outlets nationwide, with detergents mainly distributed in the southwest and cosmetics reaching all provinces. | |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes drugs for treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
